Results 111 to 120 of about 106,245 (320)

Cryptococcal meningitis due to Cryptococcus neoformans VNI in a koala (Phascolarctos cinereus) with progressive neurological disease

Australian Veterinary Journal, EarlyView.
Nearly all cases of cryptococcosis in koalas are caused by Cryptococcus gattii species complex. A rare case of meningitis due to Cryptococcus neoformans VNI/AFLP1 (abbreviated VNI) is described in a koala with nasal colonisation by both species complexes.
A Teh, R Crisman, E Dwars, R Malik, LH de Miranda, W Meyer, M Krockenberger   +6 more
wiley   +1 more source

High dose fluconazole in salvage therapy for HIV-uninfected cryptococcal meningitis

BMC Infectious Diseases, 2018
Background The 2010 Infectious Diseases Society of America (IDSA) guidelines for management of cryptococcal diseases recommend high dose fluconazole (≥ 800 mg/day), either alone or with other antifungal drugs, as alternative anticryptococcal choices. But
Hua-Zhen Zhao, Rui-Ying Wang, Xuan Wang, Ying-Kui Jiang, Ling-Hong Zhou, Jia-Hui Cheng, Li-Ping Huang, Thomas Stephen Harrison, Li-Ping Zhu   +8 more
doaj   +1 more source

Prior in vitro exposure to voriconazole confers resistance to amphotericin B in aspergillus fumigatus biofilms [PDF]

, 2015
Triazoles are the mainstay of treatment for aspergillosis, although resistance to these antifungal agents may be associated with treatment failure. Refractory infections often necessitate a switch to other antifungal agents, including amphotericin B (AmB)
Jones, Brian, Mowat, Eilidh, Rajendran, Ranjith, Ramage, Gordon, Williams, Craig   +4 more
core   +1 more source

Fluconazole Prophylaxis for the Prevention of Candidiasis in Premature Infants: A Meta-analysis Using Patient-level Data.

Clinical Infectious Diseases, 2016
BACKGROUND Invasive candidiasis (IC) is an important cause of sepsis in premature infants and is associated with a high risk of death and neurodevelopmental impairment.
J. Ericson, D. Kaufman, Stephen D. Kicklighter, J. Bhatia, D. Testoni, Jamie Gao, P. Smith, Kristi Prather, D. Benjamin, S. Macgilvray, K. Wade, M. Bidegain, R. Toms, N. Finer, David Burchfield, D. Stewart, A. Arrieta, S. Duara, S. Shankaran, Jonathan H. Nedrelow, R. White, A. Kantak, K. Shattuck, M. Pammi, K. Kennedy, P. Sánchez, C. Bendel, R. Dhanireddy, B. Bloom, M. Hudak, A. Perenyi, N. Neu, E. Ezeanolue, R. Kim, Ashley Ross, Gratias T. Mundakel, P. Pandit, B. Poindexter, R. Schelonka, P. Gordon, Katherine Y. Berezny, E. Capparelli, M. Cohen-Wolkowiez, G. Kearns, M. Laughon, I. Paul, Michael Smith, J. Anker, David Siegel, Perdita Taylor‐Zapata, A. Zajicek, Zhaoxia Ren, E. Tsilou, Alice Pagan, R. Anand, T. Clemons, Gina A. Simone   +56 more
semanticscholar   +1 more source

Feasibility of dried blood spot collection for caffeine pharmacokinetic studies in microgravity: Insights from parabolic flight campaigns

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aims Therapeutic drug monitoring for astronauts faces limitations in conventional blood sampling and sample management onboard the international space station. Here, we explore the feasibility of dried blood spot (DBS) collection during parabolic flights (PF) to overcome these constraints.
Audrey Derobertmasure, Li Shean Toh, Céline Verstuyft, Srboljub Lukic, Christelle De Sousa Carvalho, Raphaël Couronné, Marie Beauvalet, Stéphanie Chhun, Pierre Boutouyrie   +8 more
wiley   +1 more source

In vitro activities of antifungal agents alone and in combination against fluconazole-susceptible and -resistant strains of Candida dubliniensis

Brazilian Journal of Infectious Diseases
In the present study we used two groups of Candida dubliniensis strains: one containing fluconazole-susceptible clinical isolates and another containing fluconazole-resistant laboratory derivative from the former to examine the changes on susceptibility ...
Liliane Alves Scheid, Débora Alves Nunes Mario, Thaís Felli Kubiça, Janio Morais Santurio, Sydney Hartz Alves   +4 more
doaj   +1 more source

Absent in vitro interaction between chloroquine and antifungals against Aspergillus fumigatus [PDF]

, 2017
This work was supported by Medical Mycology Section, Department of Medical Microbiology, Radboud University Medical Centre, Nijmegen, the Netherlands.
Seyedmousavi, Seyedmojtaba, van der Lee, Henrich, Verweij, Paul, Warris, Adilia   +3 more
core   +1 more source

Comparison of antifungal effects of an experimental fluconazole mouthwash and nystatine mouthwash: An in vitro study

مجله دانشکده دندانپزشکی اصفهان, 2013
Introduction: Treatment of oral candidiasis with mouthwashes has several advantages. The aim of the present study was to evaluate the clinical efficacy of a new fluconazole suspension on the Candida albicans and compare its effects with those of nystatin.
Nader Navabi, Ehsan Momeni, Amin Ayatollahi, Payam Khazaeli, Abbas Pardakhti   +4 more
doaj  

Serotonin reuptake inhibitors effect on fluconazole activity against resistant Candida glabrata strains

Journal of Global Antimicrobial Resistance, 2022
: Objectives: The study aimed to evaluate four selective serotonin reuptake inhibitors (SSRIs) as modifiers of fluconazole activity against resistant strains of Candida glabrata. Methods: The effect of SSRIs on fluconazole activity was studied using the
Bashar A. Alkhalifa, Nailya R. Bulatova, Waed abuRokba, Rula M. Darwish   +3 more
doaj  

An oxindole efflux inhibitor potentiates azoles and impairs virulence in the fungal pathogen Candida auris

Nature Communications, 2020
The fungal pathogen Candida auris is resistant to multiple drugs including the common antifungal fluconazole. Here, Iyer et al. identify a compound that potentiates fluconazole activity against C.
Kali R. Iyer, Kaddy Camara, Martin Daniel-Ivad, Richard Trilles, Sheila M. Pimentel-Elardo, Jen L. Fossen, Karen Marchillo, Zhongle Liu, Shakti Singh, José F. Muñoz, Sang Hu Kim, John A. Porco, Christina A. Cuomo, Noelle S. Williams, Ashraf S. Ibrahim, John E. Edwards, David R. Andes, Justin R. Nodwell, Lauren E. Brown, Luke Whitesell, Nicole Robbins, Leah E. Cowen   +21 more
doaj   +1 more source